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Abstract
Background
Post exertional muscle fatigue is a key feature in Chronic Fatigue Syndrome (CFS). Abnor-
malities of skeletal muscle function have been identified in some but not all patients with
CFS. To try to limit potential confounders that might contribute to this clinical heterogeneity,
we developed a novel in vitro system that allows comparison of AMP kinase (AMPK) activa-
tion and metabolic responses to exercise in cultured skeletal muscle cells from CFS pa-
tients and control subjects.
Methods
Skeletal muscle cell cultures were established from 10 subjects with CFS and 7 age-
matched controls, subjected to electrical pulse stimulation (EPS) for up to 24h and exam-
ined for changes associated with exercise.
Results
In the basal state, CFS cultures showed increased myogenin expression but decreased IL6
secretion during differentiation compared with control cultures. Control cultures subjected to
16h EPS showed a significant increase in both AMPK phosphorylation and glucose uptake
compared with unstimulated cells. In contrast, CFS cultures showed no increase in AMPK
phosphorylation or glucose uptake after 16h EPS. However, glucose uptake remained re-
sponsive to insulin in the CFS cells pointing to an exercise-related defect. IL6 secretion in
response to EPS was significantly reduced in CFS compared with control cultures at all time
points measured.
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Conclusion
EPS is an effective model for eliciting muscle contraction and the metabolic changes asso-
ciated with exercise in cultured skeletal muscle cells. We found four main differences in cul-
tured skeletal muscle cells from subjects with CFS; increased myogenin expression in the
basal state, impaired activation of AMPK, impaired stimulation of glucose uptake and dimin-
ished release of IL6. The retention of these differences in cultured muscle cells from CFS
subjects points to a genetic/epigenetic mechanism, and provides a system to identify novel
therapeutic targets.
Introduction
Chronic Fatigue Syndrome (CFS) is a debilitating condition that affects approximately 600,000
people in the UK [1]. To date, little progress has been made in terms of identifying aetiological
processes in CFS. This failure to elucidate key mechanisms has impaired the development of
successful diagnostic and therapeutic approaches for the management of CFS.
Skeletal muscle fatigue is a key feature of CFS, and recent studies point to abnormalities of
muscle function in those with CFS [2, 3] with similar findings in fatigue associated chronic dis-
eases [4]. Using novel muscle magnetic resonance spectroscopy techniques studies have shown
that when CFS patients exercise some generate large amounts of acid within their muscles and
have difficulty removing acid when they finish exercising [2, 3]. However, the response to exer-
cise in patients with CFS is heterogeneous with both a variable engagement with exercise and a
variable metabolic response [2, 3, 4]. So while there is some evidence of a muscle specific defect,
no clear-cut, consistent abnormality has been found. In order to address this, we have devised
an exercise system to examine the metabolic response of cultured skeletal muscle cells in vitro.
In this way we are able to study muscle cell function under standardised conditions that re-
move the effects of potential confounders encountered in vivo that can affect the engagement
with and response to exercise.
In recent years, a number of papers have been published describing the development of a
method of inducing contraction in skeletal muscle cells using electrical pulse stimulation
(EPS). In C2C12 mouse skeletal muscle myotubes, EPS has been shown to accelerate de novo
sarcomere assembly via the induction of Ca2+ transients [5]. In this model, EPS has also been
shown to activate AMP kinase (AMPK), increase glucose transport and enhance the release of
chemokines including IL6 [6]. More recently, EPS has been described in human primary skele-
tal muscle myotubes. Enhanced sarcomere assembly, AMPK activation, increased glycolysis
and glucose uptake and increased chemokine expression are key features of this model [7, 8]
Taken together, these data indicate that EPS is an appropriate model for examining exercise-re-
lated responses in cultured cells.
In the current study, we aimed to use electrical pulse stimulation to examine muscle func-
tion using cultured skeletal muscle cells from patients with CFS and healthy controls. The mus-
cle cell cultures are derived from the satellite cells isolated from a needle muscle biopsy sample.
The isolated cells first form mononuclear myoblasts and can then be differentiated into multi-
nucleated myotubes that express key characteristics of mature native muscle [9]. An attraction
of using the muscle cell cultures is that they are subject to the same standardised conditions, so
that any differences that emerge between the CFS and control cultures will reflect changes re-
tained in the cultured cells that are therefore likely to have an epigenetic/genetic basis.
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Research Design and Methods
Study Subjects
Muscle biopsies were obtained from ten patients diagnosed with chronic fatigue syndrome and
7 healthy control subjects. Groups were matched for age and comprised males and females. All
subjects were recruited via the Newcastle NHS CFS Clinical Service at the Newcastle Hospitals
NHS Foundation Trust. All subjects fulfilled the Fukuda criteria [10] and provided written in-
formed consent. None had evidence of neurological deficit based on clinical assessment. The
study was approved by the Newcastle and North Tyneside Joint Ethics Committee.
General chemicals and reagents
Cell culture media was obtained from Lonza. FBS and trypsin-EDTA were obtained from Life
Technologies (Paisley, UK). Chick embryo extract was purchased from Sera Labs International
(Sussex, UK). Phospho-AMPKThr172 (40H9) and total AMPKα (F6) antibodies were obtained
from New England Biolabs (Herts, UK). Anti-myosin, skeletal fast (clone MY-32) and β-actin
(clone AC-15) antibodies were purchased from Sigma. Monoclonal mouse anti-human desmin
(D33) antibody was obtained from DAKO. Vector VIP HRP-substrate kit was obtained from
Vector Laboratories. 2-Deoxy-D-[2,6-3H]glucose was purchased from Hartmann Analytic
(Germany). IL6 ELISA kits were obtained from Qiagen (Sussex, UK).
Cell culture
Muscle biopsies were obtained from the vastus lateralis and muscle precursor cells isolated ac-
cording to the method of Blau and Webster [11]. Briefly, needle biopsies were collected in pro-
liferation medium (Ham’s F10 media supplemented with 20% (v/v) FBS, 2% chick embryo
extract, 1% penicillin-streptomycin), transferred to a petri dish, washed with PBS and any adi-
pose or connective tissue removed with a scalpel. The tissue was again washed with PBS then
cut into small pieces using a scalpel. The tissue was transferred to a universal containing 5ml
0.05% trypsin-EDTA and spin-digested at 37°C. After 15min, the trypsin was removed, 5ml
media added and centrifuged at 1700rpm for 5mins. The pellet containing the satellite cells was
resuspended in proliferation medium. The spin dissociation protocol was repeated a further 3
times, the pelleted cells were pooled and plated in a T25 flask. Media was changed after 24h to
remove unattached cells and cell debris. Cells were expanded in culture and proliferating myo-
blasts passaged several times before experimentation. Prior to stimulation, cells were seeded at
a density of approximately 200,000 per 35mm dish and grown to confluence before inducing
differentiation. Differentiation was induced by changing the media to minimal essential media
supplemented with 2% (v/v) FBS and 1% penicillin-streptomycin. All experiments were per-
formed on day 7 differentiated myotubes, passage 7.
Immunohistochemical staining
Muscle cell origin was confirmed immunohistochemically using antibodies to the muscle-spe-
cific protein desmin. Cells were fixed and permeabilised by incubation in ethanol at 4°C over-
night before washing with phosphate-buffered saline (PBS) and blocking in PBS containing 2%
(v/v) FBS. Cells were incubated in anti-desmin antibody at a 1:100 dilution in PBS/FBS 2% for
1hr at room temperature. After washing with PBS and a further incubation in PBS/FBS 2%,
rabbit anti-mouse HRP-conjugated secondary antibody was added at a 1:300 dilution for 1hr
at room temperature. After washing with PBS, Vector VIP HRP-substrate kit was used to de-
velop the reaction product.
Muscle Abnormalities in Chronic Fatigue Syndrome
PLOSONE | DOI:10.1371/journal.pone.0122982 April 2, 2015 3 / 14
RNA isolation and cDNA synthesis
Total RNA was extracted from human skeletal muscle cells using the GenElute Mammalian
Total RNAMiniprep kit (Sigma) following the manufacturer’s instructions. Briefly, cells were
lysed in lysis buffer containing 1% β-mercaptoethanol and applied to a filtration column. An
equal volume of 70% ethanol was added to the supernatant and passed through a nucleic-acid
binding column. Bound RNA was washed sequentially in Wash buffers 1 and 2. Finally, the
column was spin-dried and RNA eluted in a final volume of 50μl. Total RNA was treated with
DNase I and 200ng was reverse-transcribed using the High Capacity cDNA reverse transcrip-
tion kit (Applied Biosystems) in a final volume of 20μl.
Quantitative real-time PCR
Quantitative real-time PCR was performed on a Lightcycler 480 (Roche) using Taqman prim-
ers and probes. MYOG (Hs01072232_m1) was obtained from Applied Biosystems as a prede-
signed Taqman primer-probe mix and was used at the recommended 1:20 dilution.
β2-microglobulin (β2M) was used as a reference gene with sequences: For; GCCTGCC
GTGTGAACCAT, Rev; TTACATGTCTCGATCCCACTTACCTATC, Probe; FAM-TG
ACTTTGTCACAGCCCA-TAMRA. The concentration of both primers was 300nM per reac-
tion and 250nM for the probe. 10μl of Gene expression mastermix (Applied Biosystems) was
added to each reaction with 20ng of template. Results were analysed using the standard curve
method from a six-point serially diluted standard curve. Reaction efficiencies were 94.3% and
91.5% for MYOG and β2M, with correlation coefficients 0.989 and 0.997 respectively. Relative
quantification was performed with data normalised to β2-microglobulin.
Electrical pulse stimulation
Electrical pulse stimulation (EPS) was performed using a C-Pace EP cell culture pacer (IonOp-
tix, Dublin) using a two-step protocol. Cells were plated in 35mm dishes and when differentiat-
ed for 7 days, subjected to EPS at 5volts, 24ms, 2 Hz for 1h followed immediately by 5V, 24ms,
0.2Hz for 1h. This alternation between a period of high frequency and low frequency electrical
pulses was continued for the duration of stimulation of 4h, 16h and 24h. Imaging was per-
formed on an Olympus CKX41 microscope and QCapture Pro 6.0 software. Images were taken
every 200ms.
Measurement of lactate dehydrogenase (LDH) release
Lactate dehydrogenase levels were measured in the media from cells subjected to EPS for 4 and
24h using the Lactate Dehydrogenase kit (Sigma). Cells were incubated in fresh media and the
media collected at the appropriate time point. LDH release into the media was determined col-
orimetrically at 490nm according to the manufacturer’s instructions. Briefly, the lactate dehy-
drogenase assay mixture was prepared by mixing equal volumes of LDH assay substrate, dye
and cofactor solutions. Twice the volume of LDH assay solution was added to the media sam-
ple and incubated in the dark for 30min at room temperature. The reaction was stopped by the
addition of 1N HCl and the colour change read at 490nm. Total intracellular LDH for each cell
culture was measured after the addition of 0.9% Triton X-100 and LDH release normalised to
total LDH for each cell culture.
Western blotting
Cells were lysed in extraction buffer (100mM Tris-HCl, pH 7.4, 100mM KCl, 1mM EDTA,
25mM KF, 0.5mMNa3VO4, 0.1% (v/v) Triton X-100, 1x protease inhibitor cocktail (Pierce))
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before sonicating for 10s. Protein concentrations were determined spectrophotometrically at
595nm by a Coomassie binding method (Pierce). 10μg samples were prepared in Laemmli sam-
ple buffer (0.125M Tris-HCl, pH 6.8, 4% (w/v) SDS, 20% (v/v) glycerol, 10% (v/v) 2-mercap-
toethanol, and 0.004% (w/v) bromophenol blue) and boiled for 5min. After separation on 10%
SDS-PAGE gels, proteins were transferred to PVDF membranes using a mini-Hoeffer wet
transfer system. After incubation with the appropriate antibodies, detection took place using
enhanced chemiluminescence. Phospho-AMPK antibody was used at a 1:1000 dilution while
AMPK and myosin were used at a 1:2000 dilution. β-actin was used at 1:10000. Densitometry
was performed using a Bio-RADMolecular Imager GS-800 calibrated densitometer and Quan-
tity One software.
ELISA
Secretion of IL6 was determined by enzyme-linked immunosorbent assay (ELISA) using the
Single-Analyte ELISArray (Qiagen). Skeletal muscle cells were allowed to differentiate for 7
days with media samples being taken at 24h, 72h and 7 days after initiation of differentiation.
Cells were subjected to EPS for 4 and 24h 7 days after initiation of differentiation. Cells were in-
cubated in fresh media for the 24h stimulation period. After EPS, media was removed, centri-
fuged at 1000g for 10min and assayed for secretion of IL6 according to the manufacturer’s
protocol. A standard curve was generated by serial dilution of the provided antigen standard
and absorbance read at 450nm. Background absorbance was subtracted from the values and
the protein concentrations of the samples calculated from the standard curve.
Glucose uptake
After 16h EPS, cells were incubated in Krebs’ buffer (136mM NaCl, 4.7mM KCl, 1.25mM
MgSO4, 1.2mM CaCl2, 20mMHEPES, pH 7.4) with or without 100nM insulin or cytochalasin
B (10μM) for 20min. 0.1mM 2-deoxy-glucose and 0.5μCi (2,6-3H) 2-deoxyglucose were added
to each well and incubated for a further 10min. The reaction was stopped by washing the plate
rapidly in ice cold PBS. Cells were lysed in 0.05% SDS before scintillation counting and
protein determination.
Statistical analysis
All results are expressed as mean±standard error of the mean (SEM) unless where stated. Data
were analysed using one-way or two-way ANOVA where appropriate and, where significant,
followed up by t-test between groups. Statistical analyses were performed using GraphPad
Prism (California) software.
Results
Characterisation of the differentiation capacity of skeletal muscle cells
The proportion of desmin-positive cells was calculated after desmin staining by counting the
number of desmin-positive cells as a percentage of the total number of cells from 5 fields of
view for each cell culture. There were no significant differences in the percentage of desmin-
positive cells between the controls and CFS (88.9±7.8% vs 90.7±9.2%, mean±SD, p = 0.5003,
respectively).
Fig 1A shows representative light microscope images of both control and CFS cultures
taken 7 days after initiation of differentiation. Morphological measurements were made from 5
fields of view for each cell culture (Table 1). While there were no statistical differences between
control and CFS cultures in terms of length and equidiameter, area was significantly reduced in
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CFS compared to control (P<0.0001). There was no difference in myotube number between
control and CFS cultures at this time point (p = 0.1761). At the 72h time point, while myotube
number tended to be higher in the CFS compared with control cultures, this difference was not
statistically significant. There were no significant differences in length, area or equidiameter at
the 72h time point (S1 Table).
A timecourse of differentiation was undertaken to assess the differentiation capacity of cul-
tured skeletal muscle cells derived from patients with chronic fatigue syndrome compared with
control cultures. RNA extracts and media samples were taken 24h, 72h and 7 days after initia-
tion of differentiation and analysed for myogenin (MYOG) expression and IL6 release into the
media. MYOG is a myogenic regulatory factor required for terminal differentiation of
Fig 1. Analysis of the differentiation capacity of control vs CFS cultures.Representative light microscope images of 2 control (top panels) and 2 CFS
(bottom panels) cultures taken 7 days after initiation of differentiation. Images were taken at a 10x magnification (A). MYOG expression at 24h, 72h and 7
days after initiation of differentiation from control and CFS cultures was measured by QPCR (B). Data were normalised to the reference gene,
β2-microglobulin and are presented as the mean±SEM from 5 controls and 8 CFS subjects analysed in triplicate. ***p<0.0001. IL6 release into the media
was measured at 24h, 72h and 7 days after initiation of differentiation from control and CFS cultures by ELISA (C). Data are expressed as the mean±SEM
from 5 controls and 8 CFS subjects in duplicate. *p<0.05.
doi:10.1371/journal.pone.0122982.g001
Muscle Abnormalities in Chronic Fatigue Syndrome
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myotubes [12] while IL6 is a cytokine which is produced by skeletal muscle and can play a key
role in both muscle cell proliferation and differentiation [13]. MYOG expression was measured
by QPCR (Fig 1B) and showed no differences 24h after initiation of differentiation but at both
72h and 7 days, MYOG expression was significantly increased in CFS compared to control
(both p<0.0001). Measurement of IL6 release into the media (Fig 1C) indicated that IL6 release
was comparable between control and CFS cultures at 24h and 72h after initiation of differentia-
tion but at 7 days, IL6 release was significantly decreased in CFS compared to control
(p<0.05).
Development of an exercise cell culture system
Electrical pulse stimulation (EPS) was used to induce contraction in cultured myotubes from
healthy controls (S1 Video) and in cultured myotubes from patients with chronic fatigue syn-
drome (S2 Video). These cultures were subjected to 4, 16 and 24h EPS and examined for meta-
bolic changes associated with exercise in vivo. AMP-activated protein kinase (AMPK) is a
cellular energy sensor activated by a low energy status such as that seen during exercise. Activa-
tion of AMPK was assessed by Western blot using phospho-specific antibodies. In control cul-
tures (Fig 2A, left panel), phosphorylation was shown to increase with EPS and is significantly
increased at 16h (p = 0.006). In contrast, chronic fatigue cultures subjected to the same EPS
protocol showed no activation of AMPK (Fig 2A, right panel). Expression of the contractile
protein myosin heavy chain (MHC) was not altered by EPS (Fig 2B) in either control or CFS
cultures with no significant differences in expression between control and CFS at all
time points.
Cytotoxic effects of the EPS protocol were assessed by measuring the release of lactate dehy-
drogenase (LDH) into the media. Fig 2C indicates that LDH release is increased at 24h EPS
compared with 4h in both control and CFS cultures. However there are no statistical differ-
ences between the two groups at either time point.
MHC protein expression was measured in control and CFS cell cultures (B). Cells were sub-
jected to EPS and protein extracts made at the appropriate time points. Densitometry is ex-
pressed as a ratio of MHC to β-actin. Lactate dehydrogenase release (LDH) was measured in
control and CFS cell cultures (C). Media from 5 controls and 10 CFS cultures was collected
after EPS and assayed for LDH release. Data were normalised to total LDH for each cell culture.
Black bar: 4h, grey bar: 24h.
Table 1. Morphological measurements were carried out on light microscope images using Nikon
NIS-Elements AR Version 4.12 Imaging Software.
Measurement Control (Mean±SEM) CFS (Mean±SEM)
Myotube number 24±4.9 23.75±7.6
Length (μm) 392.93±8.13 477.74±8.56
Area (μm2) 9792.88±359.77 8006.71±267.94****
Equidiameter (μm) 101.71±1.72 92.86±1.28
Data are from images taken after 7 days of differentiation. Measurements were taken from 5 fields of view
for each cell culture, n = 5 cell cultures for control and n = 8 cell cultures for CFS.
****p<0.0001.
doi:10.1371/journal.pone.0122982.t001
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The effect of exercise and insulin on glucose uptake
Contraction increases the uptake of glucose into the muscle cell in an insulin-independent
manner therefore, the effect of the EPS protocol on glucose metabolism was examined by mea-
suring uptake of 2-deoxyglucose into the cells in the absence and presence of insulin. In control
cells, Fig 3A shows that under non-EPS conditions insulin-stimulated glucose uptake was in-
creased 1.3-fold over basal (447.1±25.3pmol/min/mg vs 333.5±20.2pmol/min/mg, p<0.0005).
After 16h EPS, glucose uptake increased to 550.4±35.9pmol/min/mg (p<0.0001 vs basal) while
insulin produced an additive effect in combination with EPS, increasing glucose uptake to
746.1±70.9pmol/min/mg (p<0.005 vs insulin alone). Fig 3B shows that under both non-EPS
and EPS conditions, the CFS group cultures significantly increased insulin-stimulated glucose
uptake (both p<0.0005). However, 16h EPS did not increase glucose uptake in the absence or
presence of insulin indicating that the CFS cultures were unable to increase the rate of glucose
uptake in response to exercise. This is consistent with the absence of activation of AMPK. Both
basal and insulin stimulated glucose uptake were significantly increased in CFS compared to
Fig 2. Effect of EPS on AMPK activation, MHC expression and cytotoxicity. AMPK activation was
assessed in control (left panel) and CFS (right panel) cell cultures (A). Cells were subjected to EPS and
protein extracts made at the appropriate time points. Phosphorylation of AMPK was assessed using
phospho-AMPKThr172 antibodies. Densitometry is expressed as a ratio of phosphorylated protein to total
AMPK. Open bar: unstimulated, closed bar: 4h stimulation, hatched bar: 16h stimulation, closed grey bar: 24h
stimulation. ** p = 0.006 vs unstimulated, Cultures from 7 control subjects and 8 CFS subjects.
doi:10.1371/journal.pone.0122982.g002
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control (p = 0.001 and p<0.05, respectively). However, this does not alter the finding that CFS
was unable to increase glucose uptake in response to EPS since an increase in glucose uptake
was observed only in the presence of insulin indicating that the cells are not maximally stimu-
lated in the basal state.
IL6 secretion after muscle contraction
Skeletal muscle produces IL6 in response to contraction. The effect of EPS on IL6 secretion is
shown in Fig 4. Control cells showed no change in secretion at 4h but was significantly in-
creased at 24h (p<0.001, vs unstimulated). In the CFS group, IL6 secretion showed the same
pattern of release but secretion at all time points was significantly decreased compared to
Fig 3. Measurement of glucose uptake in control and CFS cultures.Glucose uptake was measured in control (A) and CFS (B) cell cultures. Cells from 5
control and 9 CFS cell cultures were subjected to EPS for 16h before rate of glucose uptake was measured. Open bar: basal, closed bar: insulin stimulated.
Results are expressed as mean±SEM. *p<0.05, **p<0.005, ***p<0.0005, ****p<0.0001.
doi:10.1371/journal.pone.0122982.g003
Fig 4. IL6 secretion in control and CFS cell cultures. Fresh media was added to 5 controls and 10 CFS
cultures and subjected to EPS for 4 and 24h. After 24h, media was removed and assayed for IL6 secretion by
ELISA. Open bar: Unstimulated, closed bar: 4h stimulation, grey bar: 24h stimulation. Results are expressed
as mean±SEM. #p<0.001 vs control unstimulated, * p<0.05 vs corresponding control.
doi:10.1371/journal.pone.0122982.g004
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control (p<0.05 vs corresponding control), reflecting the reduced basal IL6 release
observed previously.
Discussion
We have used electrical pulse stimulation to generate key aspects of the exercise phenotype in
cultured human skeletal muscle cells. Using this method, we showed that electrical pulse stimu-
lation of cultured muscle cells from healthy control subjects resulted in the activation of
AMPK and myotube contraction that are characteristic features of exercising muscle. With this
exercise model we found two defects in cultured skeletal muscle cells from subjects with chron-
ic fatigue syndrome; impaired activation of AMPK and impaired stimulation of glucose uptake.
Interestingly, glucose uptake in response to insulin was normal in the chronic fatigue syndrome
cultures, pointing to a specific exercise related defect. The chronic fatigue syndrome and con-
trol cultures were studied under identical conditions at passage 7, making it highly probable
that the defects in the chronic fatigue cultures are due to retained defects within the cultures of
an epigenetic and/or genetic basis.
IL6 release was comparable to controls up to 72h after initiation of differentiation but was
significantly decreased in the day 7 chronic fatigue syndrome myotube cultures both before
and during contraction. Previous studies have shown no difference in circulating IL6 levels ei-
ther at rest [14, 15], or after a sub maximal exercise challenge [15] in patients with chronic fa-
tigue syndrome. However, circulating IL6 levels are likely to reflect release from multiple tissue
sources. The study we describe here is the first to examine IL6 levels released specifically from
skeletal muscle cells from patients with chronic fatigue syndrome. The importance of this de-
creased IL6 release at the late stage of muscle cell differentiation is not clear. Acute exposure of
muscle cells to IL6 and other pro-inflammatory cytokines such as tumour necrosis factor alpha
(TNFα) has been previously shown to have a myogenic role in skeletal muscle [13, 16, 17].
Treatment of C2C12 mouse myoblasts for 24h with TNFα in combination with IL6 has been
shown to promote myoblast proliferation [17]. IL6 has also been shown to be important in sat-
ellite cell proliferation in vivo with IL6-/- primary mouse myoblasts showing reduced prolifera-
tion in response to muscle overloading [18].
MYOG gene expression was significantly increased at 72h and 7 days after initiation of dif-
ferentiation in the CFS cultures compared with controls. MYOG is a myogenic regulatory fac-
tor which plays a critical role in myoblast differentiation and is a marker of terminal
differentiation [19]. MYOG expression tends to increase for the duration of differentiation,
peaking at 72–96hr after initiation of differentiation. Increased MYOG expression has been as-
sociated with increased IL6 protein release and enhanced myotube formation in cultured
C2C12 muscle cells [16, 20]. In the present study, increased MYOG expression was associated
with a reduction in IL6 release 7 days after initiation of differentiation in the CFS cultures. Im-
portantly, both control and CFS cultures were differentiated for the same length of time and
under standardised conditions before the EPS studies. MYOG expression has been implicated
in the exercise capacity of skeletal muscle. An adult mouse model of myogenin deletion showed
an enhanced capacity for exercise through the alteration of skeletal muscle metabolism [21].
Compared to their wild-type littermates, MYOG-depleted mice had an increased aerobic ca-
pacity through increased oxidative metabolism. It is possible, therefore, that increased myo-
genin expression may have a negative impact on exercise capacity. Consistent with our
findings, an earlier study demonstrated in a mouse model overexpressing myogenin that in-
creased myogenin expression was associated with smaller myofibre area [22].
The lack of activation of AMPK during EPS in muscle cells from chronic fatigue syndrome
patients points to a muscle abnormality at the level of, or upstream of, AMPK. AMPK is a
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PLOSONE | DOI:10.1371/journal.pone.0122982 April 2, 2015 10 / 14
heterotrimeric complex composed of a catalytic α subunit and regulatory β and γ subunits.
Under normal physiological conditions, AMPK is activated during muscle contraction [23].
Processes, such as muscle contraction, which increase the AMP:ATP ratio promote phosphory-
lation of AMPK on residue threonine-172 by the binding of AMP (or ADP) to the γ subunit of
AMPK. Upstream of AMPK, liver kinase B1 (LKB1) phosphorylates AMPK in most cell types
[24]. The Ca2+/calmodulin-dependent kinase kinase (CaMKK) can also phosphorylate AMPK
in a Ca2+-dependent manner in some cells [25]. A more recent study using rat skeletal muscle
as a model, suggested that, during moderate muscle contraction, glucose uptake and fatty acid
oxidation may be regulated by CaMKK and AMPK via Ca2+ signalling [26]. These kinases up-
stream of AMPK require further investigation in our cohort of CFS subjects and the availability
of our in vitro muscle system will allow rapid investigation of potential therapies potentially al-
lowing us to fast track optimised treatments to clinical trials.
There is evidence to suggest that IL6 activates AMPK [27]. In skeletal muscle of IL6 knock-
out mice, after 60min of exercise phosphorylation of AMPK was significantly reduced com-
pared with controls [28]. This study also showed that incubating EDL muscle with IL6 directly
increased AMPK phosphorylation. More recently, it has been proposed that IL6 activates
AMPK by increasing both cAMP levels and the AMP:ATP ratio [29]. However, the exact
mechanism involved is still unknown. In humans, IL6 release from the leg has been shown to
correlate significantly with AMPK activity during ergometer cycling [30]. Whether the dimin-
ished IL6 release from the CFS muscle cultures contributes to the impaired activation of
AMPK warrants further investigation. There is, however, also evidence to suggest that AMPK
can regulate IL6 release from skeletal muscle [31].
Electrical pulse stimulation provides an in vitro system which allows pre-clinical testing of
molecules that could manipulate the biochemical abnormalities seen. Studying those areas of
the metabolic pathway that are deficient in patients with CFS and how these might be pharma-
cologically manipulated would represent an opportunity to ‘fast track’ existing or novel thera-
pies to clinical trials in CFS. In addition to this pre-clinical experimental system allowing us to
understand more fully the physiological basis of CFS it could also provide an opportunity to ex-
plore fatigue pathogenesis in other fatigue associated chronic diseases. While monolayer cul-
tures provide a good model for studying the response to exercise in vitro, a potential limitation
of the model is that in 2D cultures the myotubes are not completely aligned. One way to ad-
dress this is by developing a 3D cell culture system. A number of studies have now been re-
ported where either C2C12 myoblasts [32, 33] or primary rat myoblasts [34–36] have been
grown and differentiated in a 3D culture environment which mimics more closely the structur-
al, functional and myogenic properties of native muscle. A recent study has also described the
3D culture properties of primary human skeletal muscle cells [37]. Exercise stimulation in 3D
culture is not yet well described but is an important consideration for future experiments.
Recent studies suggest that graded exercise therapy (GET) has benefits for patients with
CFS [38] although these benefits have been small. Frequently patients with CFS feel that exer-
cise in fact makes their symptoms worse. Our recent MRS studies suggested that there were at
least two muscle phenotypes grouped together through the entirely symptom based diagnostic
classification of CFS. This might explain, in part, the limited benefits seen in the PACE trial for
GET. We believe that the results of the current study further emphasise the potential for a pe-
ripheral component to CFS and the need to fully characterise the muscle phenotypes in CFS be-
fore generically prescribing exercise as an effective intervention. Further work is needed to
understand the muscle biochemical abnormalities in CFS and the impact that exercise might
have upon these.
In conclusion, alternating frequency EPS is an effective model for eliciting muscle contrac-
tion and the metabolic changes associated with exercise. The failure of AMPK activation and
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glucose uptake in response to EPS point to a primary abnormality in the muscle of patients
with chronic fatigue syndrome. Mechanisms involved in the activation of AMPK in those with
CFS and fatigue associated chronic diseases require further investigation.
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